[1. Chun Y, Lee DI, Kwon J, et al. Comparison of impact of monocular and integrated binocular visual fields on vision- related quality of life. J Glaucoma. 2017;26:283–291.10.1097/IJG.000000000000062328079653]Search in Google Scholar
[2. van Gestel A, Webers CA, Beckers HJ, et al. The relationship between visual field loss in glaucoma and health-related quality-of-life. Eye (Lond). 2010;24:1759–1769.10.1038/eye.2010.13321057519]Search in Google Scholar
[3. Asaoka R, Crabb DP, Yamashita T, et al. Patients have two eyes!: binocular versus better eye visual field indices. Invest Ophthalmol Vis Sci. 2011;52:7007–7011.10.1167/iovs.11-764321810985]Search in Google Scholar
[4. Lisboa R, Chun YS, Zangwill LM, et al. Association between rates of binocular visual field loss and vision-related quality of life in patients with glaucoma. JAMA Ophthalmol. 2013;131:486–494.10.1001/jamaophthalmol.2013.2602380426423450425]Search in Google Scholar
[5. Cheng HC, Guo CY, Chen MJ, et al. Patient-reported vision- related quality of life differences between superior and inferior hemifield visual field defects in primary open-angle glaucoma. JAMA Ophthalmol. 2015;133:269–275.10.1001/jamaophthalmol.2014.490825429608]Search in Google Scholar
[6. Quaranta L, Riva I, Gerardi C, et al. Quality of life in glaucoma: a review of the literature. Adv Ther. 2016;33:959–981.10.1007/s12325-016-0333-6492085127138604]Search in Google Scholar
[7. Murata H, Hirasawa H, Aoyama Y, et al. Identifying areas of the visual field important for quality of life in patients with glaucoma. PLoS One. 2013;8:e58695.10.1371/journal.pone.0058695359281423520528]Search in Google Scholar
[8. Kwon M, Huisingh C, Rhodes LA, et al. Association between glaucoma and at-fault motor vehicle collision involvement among older drivers: a population-based study. Ophthalmology. 2016;123:109–116.10.1016/j.ophtha.2015.08.043469530326459997]Search in Google Scholar
[9. Diniz-Filho A, Boer ER, Elhosseiny A, et al. Glaucoma and driving risk under simulated fog conditions. Transl Vis Sci Technol. 2016;5:15.10.1167/tvst.5.6.15515644527980878]Search in Google Scholar
[10. Kubler TC, Kasneci E, Rosenstiel W, et al. Driving with glaucoma: task performance and gaze movements. Optom Vis Sci. 2015;92:1037–1046.10.1097/OPX.000000000000070226501733]Search in Google Scholar
[11. van Landingham SW, Hochberg C, Massof RW, et al. Driving patterns in older adults with glaucoma. BMC Ophthalmol. 2013;13:4.10.1186/1471-2415-13-4]Search in Google Scholar
[12. Nguyen AM, van Landingham SW, Massof RW, et al. Reading ability and reading engagement in older adults with glaucoma. Invest Ophthalmol Vis Sci. 2014;55:5284–’35290.10.1167/iovs.14-14138]Search in Google Scholar
[13. Yang Y, Trope GE, Buys YM, et al. Glaucoma severity and participation in diverse social roles: does visual field loss matter? J Glaucoma. 2016;25:e697–e703.10.1097/IJG.0000000000000353]Search in Google Scholar
[14. Janz NK,Wren PA, Lichter PR, et al. Quality of life in newly diagnosed glaucoma patients: the Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2001;108:887–897 discussion 898.10.1016/S0161-6420(00)00624-2]Search in Google Scholar
[15. Ramli N, Supramaniam G, Samsudin A, et al. Ocular surface disease in glaucoma: effect of polypharmacy and preservatives. Optom Vis Sci. 2015;92:e222–e226.10.1097/OPX.000000000000054225730335]Search in Google Scholar
[16. Pouyeh B, Viteri E, FeuerW, et al. Impact of ocular surface symptoms on quality of life in a United States veterans affairs population. Am J Ophthalmol. 2012;153:1061–1066. e3.10.1016/j.ajo.2011.11.03022330309]Search in Google Scholar
[17. Rossi GC, Tinelli C, Pasinetti GM, et al. Dry eye syndrome- related quality of life in glaucoma patients. Eur J Ophthalmol. 2009;19:572–579.10.1177/11206721090190040919551671]Search in Google Scholar
[18. Cvenkel B, Stunf S, Srebotnik K, et al. Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma. Clin Ophthalmol. 2015;9: 625–631.10.2147/OPTH.S81247439951825914521]Search in Google Scholar
[19. Perez-Bartolome F, Martinez-de-la-Casa JM, Arriola- Villalobos P, et al. Ocular surface disease in patients under topical treatment for glaucoma. Eur J Ophthalmol. 2017;27: 694–704.10.5301/ejo.500097728497458]Search in Google Scholar
[20. Terai N, Muller-Holz M, Spoerl E, et al. Short-term effect of topical antiglaucoma medication on tear-film stability, tear secretion, and corneal sensitivity in healthy subjects. Clin Ophthalmol. 2011;5:517–525.10.2147/OPTH.S18849309030821573041]Search in Google Scholar
[21. Anwar Z, Wellik SR, Galor A. Glaucoma therapy and ocular surface disease: current literature and recommendations. Curr Opin Ophthalmol. 2013;24:136–143.10.1097/ICU.0b013e32835c8aba]Search in Google Scholar
[22. Tsai JC. A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology. 2009;116 (suppl):S30–S36.10.1016/j.ophtha.2009.06.024]Search in Google Scholar
[23. Janz NK, Wren PA, Lichter PR, et al. The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology. 2001;108:1954–1965.10.1016/S0161-6420(01)00874-0]Search in Google Scholar
[24. J Ophthalmol. 2017:1–7. King AJ, Fernie G, Azuara- Blanco A, et al. Treatment of Advanced Glaucoma Study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma-study protocol. Br.]Search in Google Scholar
[25. Zimmerman T, Karunaratne N, Fechtner R. Glaucoma: outcomeology (part I, II). J Glaucoma. 1996;5:151–155.10.1097/00061198-199606000-00001]Search in Google Scholar
[26. Spaeth G, Walt J, Keener J. Evaluation of quality of life for patients with glaucoma. Am J Ophthalmol. 2006;141 (suppl):S3–S14.10.1016/j.ajo.2005.07.075]Search in Google Scholar
[27. Wilson MR, Coleman AL, Yu F, et al. Functional status and well-being in patients with glaucoma as measured by the Medical Outcomes Study Short Form-36 questionnaire. Ophthalmology. 1998;105:2112–2116.10.1016/S0161-6420(98)91135-6]Search in Google Scholar
[28. Aspinall PA, Johnson ZK, Azuara-Blanco A, et al. Evaluation of quality of life and priorities of patients with glaucoma. Invest Ophthalmol Vis Sci. 2008;49:1907–1915.10.1167/iovs.07-055918436824]Search in Google Scholar
[29. Khanna CL, Leske DA, Holmes JM. Factors associated with health-related quality of life in medically and surgically treated patients with glaucoma. JAMA Ophthalmol. 2018.10.1001/jamaophthalmol.2018.0012587684729470573]Search in Google Scholar
[30. Nutheti R, Shmanna BR, Nirmalan PK, et al. Impact of impaired vision and eye disease on quality of life in Andhra Pradesh. Invest Ophthalmol Vis Sci. 2006;47: 4742–4748.10.1167/iovs.06-002017065482]Search in Google Scholar
[31. Peters D, Heijl A, Brenner L, et al. Visual impairment and vision-related quality of life in the Early Manifest Glaucoma Trial after 20 years of follow-up. Acta Ophthalmol. 2015;93:745–752.10.1111/aos.12839501420826382936]Search in Google Scholar
[32. Goldberg I, Clement CI, Chiang TH, et al. Assessing quality of life with glaucoma using the Glaucoma Quality of Life-15 (GQL-15) questionairre. J Glaucoma. 2009;18: 6–12.10.1097/IJG.0b013e3181752c8319142128]Search in Google Scholar
[33. Day DG, Sharpe Ed, Atkinson MJ, et al. The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients. Eye (London). 2006;20:583–590.10.1038/sj.eye.670193215933751]Search in Google Scholar
[34. Jampel HD, Frick KD, Janz NK, et al. Depression and mood indicators in newly diagnosed glaucoma patients. Am J Ophthalmol. 2007;144:238–244.10.1016/j.ajo.2007.04.04817560843]Search in Google Scholar
[35. Mabuchi F, Yoshimura K, Kashiwagi K, et al. High prevalence of anxiety and depression in patients with primary opan-angle glaucoma. J Glaucoma. 2008;17: 552–557.10.1097/IJG.0b013e31816299d418854732]Search in Google Scholar
[36. Tastan S, Iyigun E, Bayer A, et al. Anxiety, depression, and quality of life in Turkish patients with glaucoma. Psychol Rep. 2010;106:343–357.10.2466/pr0.106.2.343-357]Search in Google Scholar
[37. Zhou C, Qian S, Wu P, et al. Anxiety and depression in Chinese patients with glaucoma: sociodemographic, clinical, and self-reported correlates. J Psychosom Res. 2013;75:72–82.10.1016/j.jpsychores.2013.03.00523751243]Search in Google Scholar
[38. Mabuchi F, Yoshimura K, Kashiwagi K, et al. Risk factors for anxiety and depression in patients with glaucoma. Br J Ophthalmol. 2012;96:821–825.10.1136/bjophthalmol-2011-30091022353697]Search in Google Scholar
[39. Skalicky S, Goldberg I. Depression and quality of life in patients with glaucoma: a cross-sectional analysis using the Geriatric Depression Scale-15, Assessment of Function Related to Vision, and the Glaucoma Quality of Life-15. J Glaucoma. 2008;17: 546–5.10.1097/IJG.0b013e318163bdd118854731]Search in Google Scholar
[40. Stryker JE, Beck AD, Primo SA, et al. An exploratory study of factors influencing glaucoma treatment adherence. J Glaucoma. 2010;19:66–72.10.1097/IJG.0b013e31819c4679280819720075676]Search in Google Scholar
[41. Yochim BP, Mueller AE, Kane KD, et al. Prevalence of cognitive impairment, depression, and anxiety symptoms among older adults with glaucoma. J Glaucoma. 2012;21:250–254.10.1097/IJG.0b013e3182071b7e21336151]Search in Google Scholar